The association between lower back pain and health status, work productivity, and health care resource use in Japan

被引:43
作者
Sadosky, Alesia B. [1 ]
DiBonaventura, Marco [2 ]
Cappelleri, Joseph C. [3 ]
Ebata, Nozomi [4 ]
Fujii, Koichi [4 ]
机构
[1] Pfizer Inc, New York, NY USA
[2] Kantar Hlth, New York, NY 10010 USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Pfizer Japan Inc, Tokyo, Japan
来源
JOURNAL OF PAIN RESEARCH | 2015年 / 8卷
关键词
low back pain; pain severity; quality of life; cost; QUALITY-OF-LIFE; GLOBAL BURDEN; POPULATION; PREVALENCE; VALIDITY; SLEEP; AGE;
D O I
10.2147/JPR.S76649
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: This study investigated the effect of pain severity on health status, work productivity, health care resource use, and costs among respondents with lower back pain (LBP), in Japan. Materials and methods: Data from the 2013 Japan National Health and Wellness Survey, a survey of Japanese adults, were analyzed (N=30,000). All respondents provided informed consent, and the protocol was institutional review board-approved. Respondents who reported experiencing LBP were propensity score-matched to those without LBP, based on demographics and health history. Using regression modeling, patients with mild, moderate, and severe pain were compared against matched controls, with respect to health status (Mental and Physical Component Summary scores, and health utilities from the Short Form (R)-36 Health Survey version 2), work productivity (Work Productivity and Activity Impairment - General Health version), health care resource use, and annual per-patient costs (estimated using published annual wages and resource use event costs). Results: A total 1,897 patients reported experiencing LBP in the past month (6.32%); 52.45% reported their pain as mild, 32.79% as moderate, and 14.76% as severe. Increasing pain severity was associated with significantly lower levels of mental component scores (46.99 [mild], 42.93 [moderate], and 40.58 [severe] vs 48.10 [matched controls]), physical component scores (50.29 [mild], 46.74 [moderate], and 43.94 [severe] vs 52.93 [matched controls]), and health utilities (0.72 [mild], 0.66 [moderate], and 0.62 [severe] vs 0.76 [matched controls]) (all P<0.05). Indirect costs were significantly higher (P<0.05) among those with moderate ((sic)1.69 million [MM] [equivalent to $17,000, based on United States dollar exchange rates on September 1, 2014]) and severe ((sic)1.88 MM [$19,000]) pain, relative to matched controls ((sic)0.95 MM [$9,500]). Direct costs were only marginally different (P=0.05) between those with severe pain and matched controls ((sic)1.33 MM [$13,000] vs (sic)0.54 MM [$5,000]). Conclusion: Increasing pain severity among respondents with LBP was associated with significantly worse health status, to a clinically-relevant degree, along with greater indirect and direct costs, in Japan.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 27 条
  • [1] [Anonymous], HLTH GLANC 2011 OECD
  • [2] [Anonymous], EFF AN OUTP VIS OPT
  • [3] [Anonymous], 2013 FISC YEAR TREND
  • [4] [Anonymous], LIGHTSP RES PAN BOOK
  • [5] Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
    Barba, C
    Cavalli-Sforza, T
    Cutter, J
    Darnton-Hill, I
    Deurenberg, P
    Deurenberg-Yap, M
    Gill, T
    James, P
    Ko, G
    Miu, AH
    Kosulwat, V
    Kumanyika, S
    Kurpad, A
    Mascie-Taylor, N
    Moon, HK
    Nishida, C
    Noor, MI
    Reddy, KS
    Rush, E
    Schultz, JT
    Seidell, J
    Stevens, J
    Swinburn, B
    Tan, K
    Weisell, R
    Wu, ZS
    Yajnik, CS
    Yoshiike, N
    Zimmet, P
    [J]. LANCET, 2004, 363 (9403) : 157 - 163
  • [6] Placing the global burden of low back pain in context
    Buchbinder, Rachelle
    Blyth, Fiona M.
    March, Lyn M.
    Brooks, Peter
    Woolf, Anthony D.
    Hoy, Damian G.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2013, 27 (05): : 575 - 589
  • [7] Carter MJ, 2014, THER RECREAT J, V48, P275
  • [8] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [9] Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan
    Fukuhara, S
    Bito, S
    Green, J
    Hsiao, A
    Kurokawa, K
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) : 1037 - 1044
  • [10] Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey
    Fukuhara, S
    Ware, JE
    Kosinski, M
    Wada, S
    Gandek, B
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) : 1045 - 1053